190 related articles for article (PubMed ID: 26090964)
1. Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.
Kato CD; Alibu VP; Nanteza A; Mugasa CM; Matovu E
PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003835. PubMed ID: 26090964
[TBL] [Abstract][Full Text] [Related]
2. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.
MacLean L; Reiber H; Kennedy PG; Sternberg JM
PLoS Negl Trop Dis; 2012; 6(10):e1857. PubMed ID: 23145191
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients.
Maclean L; Odiit M; Sternberg JM
Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):270-5. PubMed ID: 16343570
[TBL] [Abstract][Full Text] [Related]
4. Plasma cytokines quantification among
Kamoto K; Chiwaya A; Nambala P; Chammudzi P; Senga E; Chisi J; Matovu E; Musaya J
Malawi Med J; 2021 Dec; 33(4):230-235. PubMed ID: 35291381
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda.
Kuepfer I; Hhary EP; Allan M; Edielu A; Burri C; Blum JA
PLoS Negl Trop Dis; 2011 Mar; 5(3):e968. PubMed ID: 21407802
[TBL] [Abstract][Full Text] [Related]
6. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
[TBL] [Abstract][Full Text] [Related]
7. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.
Hainard A; Tiberti N; Robin X; Lejon V; Ngoyi DM; Matovu E; Enyaru JC; Fouda C; Ndung'u JM; Lisacek F; Müller M; Turck N; Sanchez JC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e459. PubMed ID: 19554086
[TBL] [Abstract][Full Text] [Related]
8. IL-6 is upregulated in late-stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Nyawira Maranga D; Kagira JM; Kinyanjui CK; Muturi Karanja S; Wangari Maina N; Ngotho M
Clin Dev Immunol; 2013; 2013():320509. PubMed ID: 24194772
[TBL] [Abstract][Full Text] [Related]
9. Plasma cytokine profiles associated with
Nsubuga J; Kato CD; Nanteza A; Matovu E; Alibu VP
Allergy Asthma Clin Immunol; 2019; 15():63. PubMed ID: 31687034
[TBL] [Abstract][Full Text] [Related]
10. Clinical profiles, disease outcome and co-morbidities among T. b. rhodesiense sleeping sickness patients in Uganda.
Kato CD; Nanteza A; Mugasa C; Edyelu A; Matovu E; Alibu VP
PLoS One; 2015; 10(2):e0118370. PubMed ID: 25719539
[TBL] [Abstract][Full Text] [Related]
11. Thyroid dysfunction in African trypanosomiasis: a possible role for inflammatory cytokines.
Reincke M; Allolio B; Petzke F; Heppner C; Mbulamberi D; Vollmer D; Winkelmann W; Chrousos GP
Clin Endocrinol (Oxf); 1993 Oct; 39(4):455-61. PubMed ID: 8287572
[TBL] [Abstract][Full Text] [Related]
12. Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense.
MacLean LM; Odiit M; Chisi JE; Kennedy PG; Sternberg JM
PLoS Negl Trop Dis; 2010 Dec; 4(12):e906. PubMed ID: 21151878
[TBL] [Abstract][Full Text] [Related]
13. Plasma Neuron-Specific Enolase is not a reliable biomarker for staging Trypanosoma brucei rhodesiense sleeping sickness patients.
Kato CD; Twesigye D; Alibu VP; Nanteza A; Nsubuga J; Mugasa CM; Matovu E
BMC Res Notes; 2022 Mar; 15(1):97. PubMed ID: 35255971
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense Infection.
Lamour SD; Alibu VP; Holmes E; Sternberg JM
J Infect Dis; 2017 Dec; 216(10):1273-1280. PubMed ID: 28927234
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine Pathway Activation in Human African Trypanosomiasis.
Sternberg JM; Forrest CM; Dalton RN; Turner C; Rodgers J; Stone TW; Kennedy PGE
J Infect Dis; 2017 Mar; 215(5):806-812. PubMed ID: 28013248
[TBL] [Abstract][Full Text] [Related]
16. Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile.
MacLean L; Chisi JE; Odiit M; Gibson WC; Ferris V; Picozzi K; Sternberg JM
Infect Immun; 2004 Dec; 72(12):7040-4. PubMed ID: 15557627
[TBL] [Abstract][Full Text] [Related]
17. Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology.
Sternberg JM; Rodgers J; Bradley B; Maclean L; Murray M; Kennedy PG
J Neuroimmunol; 2005 Oct; 167(1-2):81-9. PubMed ID: 16054238
[TBL] [Abstract][Full Text] [Related]
18. The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness.
Kato CD; Matovu E; Mugasa CM; Nanteza A; Alibu VP
Allergy Asthma Clin Immunol; 2016; 12():4. PubMed ID: 26807135
[TBL] [Abstract][Full Text] [Related]
19. The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda.
Fèvre EM; Coleman PG; Odiit M; Magona JW; Welburn SC; Woolhouse ME
Lancet; 2001 Aug; 358(9282):625-8. PubMed ID: 11530149
[TBL] [Abstract][Full Text] [Related]
20. Blood signatures for second stage human African trypanosomiasis: a transcriptomic approach.
Mulindwa J; Matovu E; Enyaru J; Clayton C
BMC Med Genomics; 2020 Jan; 13(1):14. PubMed ID: 32000760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
